Therapeutic Potential of Bacteria against Solid Tumors

Area of Science:

• Oncology
• Immunology
• Microbiology

Background:

• Bacterial infections show potential for antitumor responses but face clinical limitations due to low success rates and side effects.
• Existing approaches require optimization for efficacy and safety in cancer treatment.

Purpose of the Study:

• To investigate the impact of varying bacterial loads and tumor necrosis factor alpha (TNFα) on antitumor responses in murine cancer models.
• To develop a predictive model for bacterial therapy outcomes based on tumor characteristics and immune dynamics.

Main Methods:

• Titration of bacteria and/or TNFα in established murine cancer models.
• Utilized a calibrated tumor-effector cell recruitment model incorporating tumor vasculature.
• Analyzed pretreatment tumor size and immune cell recruitment dynamics to predict outcomes.

Main Results:

• Bacterial infections and TNFα modulated immune activity and tumor vascularization.
• Optimal bacterial loads were influenced by tumor size, with higher loads not always yielding better long-term control.
• Short-term responses correlated with high effector cell concentrations, but not necessarily with sustained immune surveillance restoration.

Conclusions:

• A combination of intermediate bacterial loads and low-level TNFα administration may offer improved outcomes for bacterial-based cancer therapies.
• Tumor size and immune recruitment dynamics are critical factors in predicting and optimizing bacterial therapy efficacy.